SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 125 filers reported holding SERES THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,935 | -56.2% | 10,897 | -11.9% | 0.00% | -57.1% |
| Q2 2023 | $59,224 | -15.5% | 12,364 | 0.0% | 0.01% | -22.2% |
| Q1 2023 | $70,104 | +1.3% | 12,364 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $69,238 | -12.4% | 12,364 | 0.0% | 0.01% | -18.2% |
| Q3 2022 | $79,000 | +88.1% | 12,364 | 0.0% | 0.01% | +83.3% |
| Q2 2022 | $42,000 | -52.3% | 12,364 | 0.0% | 0.01% | -40.0% |
| Q1 2022 | $88,000 | -5.4% | 12,364 | +10.7% | 0.01% | 0.0% |
| Q4 2021 | $93,000 | – | 11,164 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 14,378,802 | $342,935,000 | 4.38% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 122,700 | $2,926,000 | 1.30% |
| COMMODORE CAPITAL LP | 145,453 | $3,469,000 | 1.21% |
| Asymmetry Capital Management, L.P. | 63,259 | $1,509,000 | 1.04% |
| Opaleye Management Inc. | 250,000 | $5,963,000 | 0.99% |
| Ikarian Capital, LLC | 500,000 | $11,924,000 | 0.96% |
| HighVista Strategies LLC | 44,750 | $1,068,000 | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 63,915 | $1,524,000 | 0.68% |
| Altium Capital Management LP | 104,626 | $2,495,000 | 0.58% |
| Integral Health Asset Management, LLC | 75,000 | $1,789,000 | 0.49% |